Keira Bell
Detransitioner and legal campaigner
Keira Bell's legal challenge against the NHS Tavistock clinic sent shockwaves through British healthcare. As a teenager she was prescribed puberty blockers and testosterone by the Gender Identity Development Service; as a young adult she detransitioned. Her landmark High Court case helped trigger the scrutiny that led to GIDS's closure — a story at the centre of Britain's reckoning with gender medicine.
Keira Bell was referred to the NHS Gender Identity Development Service (GIDS) at the Tavistock and Portman NHS Foundation Trust as a teenager, and was prescribed puberty blockers at sixteen and testosterone at eighteen. She later detransitioned, concluding that the medical pathway she had been placed on was not right for her. Her experience led her to question whether a young person could meaningfully consent to treatments whose long-term consequences were poorly understood.
In 2020 Bell brought a judicial review against the Tavistock — the case known as Bell v Tavistock — challenging the clinic's prescribing of puberty blockers to under-18s. The High Court initially found in her favour, ruling that children under sixteen were unlikely to be able to give informed consent to puberty blockers. Although the Court of Appeal later overturned that specific finding, the case placed intense public and parliamentary scrutiny on GIDS at a pivotal moment. That scrutiny fed directly into the independent Cass Review, which recommended the service's closure; NHS England subsequently wound GIDS down.
In The DARK Reality Behind 'Gender Affirming Care' - Keira Bell (#2) (February 2025), she speaks with Stella O'Malley and Dr Bret Alderman about the lived experience behind those legal headlines: what it felt like to be a distressed teenager guided onto a medical pathway, the physical and psychological consequences of her transition, and the years she spent piecing together what had happened to her before she stepped into a courtroom.
Bell's story is among the most consequential in recent NHS history — not only for its legal impact but for the questions it forced into the open about safeguarding, consent, and the duties owed to gender-questioning young people. For British listeners, her account is inseparable from the institutions at its heart: the Tavistock, GIDS, and the courts that were ultimately asked to rule on whether children could give valid consent to experimental medicine.
